Important Notes
| Applications will open on Thursday, October 1 on the Foundant Technologies Website. |
| These grants skipped the letter of intent (LOI) stage and do NOT require an invitation to submit. |
| Applicants are strongly advised to read the instructions and eligibility criteria before starting an application. |
Anticipated Timeline
| October 1, 2020 | Full Application Submission Opens |
| December 1, 2020 | Full Application Deadline due by 11:59 pm Eastern Time |
| January 2021 | Grantee Notification |
| February 2021 | Grant Start Date |
Current Partner Grant Opportunities
ATS/4DX Medical Research Grant in Asthma using X-ray Velocimetry (XV) Lung Ventilation Analysis Software (LVAS)
1 grant available |
| Target Audience: Investigators interested in research in Asthma using X-ray Velocimetry (XV) Lung Ventilation Analysis Software (LVAS) |
| The focus of this research grant is proposals that are conducting research in asthma using X-ray Velocimetry (XV) Lung Ventilation Analysis Software (LVAS). Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or subject enrollment fees directly related to the project or other allowable costs. Travel for the PI for purposes of presenting data related to the project is limited to $2,000 per year. Indirect costs will not be paid to the sponsoring institution. |
| Award-specific eligibility: • Junior investigators (as defined here) • Must meet eligibility requirements for all grants found here |
| Fully funded by 4DX Medical. Please visit 4dmedical.com for more information about our partner. |
ATS/4DX Medical Research Grant in COPD using X-ray Velocimetry (XV) Lung Ventilation Analysis Software (LVAS)1 grant available$50,000 for 1 year |
| Target Audience: Investigators interested in research in COPD using X-ray Velocimetry (XV) Lung Ventilation Analysis Software (LVAS) |
| The focus of this research grant is proposals that are conducting research in COPD using X-ray Velocimetry (XV) Lung Ventilation Analysis Software (LVAS). Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or subject enrollment fees directly related to the project or other allowable costs. Travel for the PI for purposes of presenting data related to the project is limited to $2,000 per year. Indirect costs will not be paid to the sponsoring institution. |
| Award-specific eligibility: • Junior investigators (as defined here) • Must meet eligibility requirements for all grants found here |
| Fully funded by 4DX Medical. Please visit 4dmedical.com for more information about our partner. |
ATS/4DX Medical Research Grant in IPF using X-ray Velocimetry (XV) Lung Ventilation Analysis Software (LVAS)1 grant available$40,000 per year for 2 years |
| Target Audience: Investigators interested in research in IPF using X-ray Velocimetry (XV) Lung Ventilation Analysis Software (LVAS) |
|
The focus of this research grant is proposals that are conducting research in IPF using X-ray Velocimetry (XV) Lung Ventilation Analysis Software (LVAS). Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or subject enrollment fees directly related to the project or other allowable costs. Travel for the PI for purposes of presenting data related to the project is limited to $2,000 per year. Indirect costs will not be paid to the sponsoring institution. |
| Award-specific eligibility: • Junior investigators (as defined here) • Must meet eligibility requirements for all grants found here |
| Fully funded by 4DX Medical. Please visit 4dmedical.com for more information about our partner. |
ATS/Mallinckrodt Research Grant on COVID-19 in Underrepresented Minorities1 grant available$50,000 per year for 1 year |
| Target Audience: Investigators interested in research on COVID-19 in underrepresented minority (URM) patient populations |
| The focus of this research grant is research that contributes to the understanding of COVID-19 that disproportionately affects underrepresented minority (URM) patient groups. URM patient groups includes patients from lower-middle and low-income countries as defined by the World Bank, or the following North American populations: African Americans, Mexican-Americans, Native Americans (American Indians, Alaska Natives, and native Hawaiians), Pacific Islanders, and mainland Puerto Ricans. Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or subject enrollment fees directly related to the project or other allowable costs. Travel for the PI for purposes of presenting data related to the project is limited to $2,000 per year. Indirect costs will not be paid to the sponsoring institution. |
| Award-specific eligibility: • Junior investigators (as defined here) • Must meet eligibility requirements for all grants found here |
| Fully funded by Mallinckrodt Pharmaceuticals. Please visit mallinckrodt.com for more information about our partner. |
ATS/Mallinckrodt Research Grant on Sarcoidosis1 grant available$50,000 for 1 year |
| Target Audience: Investigators interested in research that is relevant to sarcoidosis |
| The focus of this research grant is proposals that advance understanding of sarcoidosis. Applicants may request up to $50,000 for 1 year. Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or subject enrollment fees directly related to the project or other allowable costs. Travel for the PI for purposes of presenting data related to the project is limited to $2,000 per year. Indirect costs will not be paid to the sponsoring institution. |
| Award-specific eligibility: • Junior investigators (as defined here) • Must meet eligibility requirements for all grants found here |
| Fully funded by Mallinckrodt Pharmaceuticals. Please visit mallinckrodt.com for more information about our partner. |
Review Process
Please note that after you submit your application it will be reviewed by Research Program staff. If there are any problems or if these guidelines have not been followed, your proposal will be un-submitted. Please make sure that you check your email after you submit your application so that any outstanding issues may be addressed as quickly as possible.
The ATS Scientific Advisory Committee (SAC) will review the applications in July 2020. The membership of the SAC is listed on the ATS Website and additional ad hoc reviewers will be invited to participate as needed. Funding decisions will be made on the basis of scientific merit, novelty, and responsiveness to the purpose of the specific grant program.
ATS Policy on Additional Grant Funding
Simultaneous submission of grants with scientific overlap is allowed, but if multiple applications are funded, then the applicant must notify the Research Program within one month of formal notification of award. A subcommittee of the SAC will assess the degree of overlap. In the case of significant scientific overlap, the applicant will have to choose between the ATS Foundation research grant and the other grant. Budgetary overlap is not allowed.
If your question is not answered in the FAQ, contact the Research Program at researchprogram@thoracic.org.
